Posttranscriptional Interaction Between miR-450a-5p and miR-28-5p and STAT1 mRNA Triggers Osteoblastic Differentiation of Human Mesenchymal Stem Cells

Journal of Cellular Biochemistry

Volumn 118, Issue 11, 2017, Pages 4045-4062

  Dernowsek, Janaína A ^a   Pereira, Milena C ^a   Fornari, Thaís A ^a   Macedo, Claudia ^a   Assis, Amanda F ^a   Donate, Paula B ^a   Bombonato Prado, Karina F ^a   Passos Bueno, Maria Rita ^a   Passos, Geraldo A ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

microRNA ANTAGONIST; microRNA MIMIC; miR 450a 5p; OSTEOBLASTIC DIFFERENTIATION; POSTTRANSCRIPTIONAL CONTROL; RUNX2; STAT1

Indexed keywords

MICRORNA; MICRORNA 145 3P; MICRORNA 17 3P; MICRORNA 28 5P; MICRORNA 29B; MICRORNA 29C 5P; MICRORNA 450A 5P; STAT1 PROTEIN; TRANSCRIPTION FACTOR RUNX1; UNCLASSIFIED DRUG; MESSENGER RNA; MIRN28 MICRORNA, HUMAN; MIRN450 MICRORNA, HUMAN; STAT1 PROTEIN, HUMAN;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; GENETIC TRANSFECTION; GENOMICS; HUMAN; HUMAN CELL; IN VITRO STUDY; MESENCHYMAL STEM CELL; MICROARRAY ANALYSIS; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN RNA BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION; TRANSCRIPTION REGULATION; UPREGULATION; CYTOLOGY; GENETICS; MALE; MESENCHYMAL STROMA CELL; METABOLISM; PRESCHOOL CHILD;

CELL DIFFERENTIATION; CHILD, PRESCHOOL; HUMANS; MALE; MESENCHYMAL STROMAL CELLS; MICRORNAS; OSTEOBLASTS; RNA, MESSENGER; STAT1 TRANSCRIPTION FACTOR;

EID: 85019617064     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.26060     Document Type: Article

References (54)

1. Bartel DP. 2004. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116:281–297.
2. Bonewald LF, Johnson ML. 2008. Osteocytes, mechanosensing and Wnt signaling. Bone 42:606–615.
3. Bonewald LF, Kiel DP, Clemens TL, Esser K, Orwoll ES, O'Keefe RJ, Fielding RA. 2013. Forum on bone and skeletal muscle interactions: Summary of the proceeding of an ASBMR workshop. J Bone Miner Res 28:1857–1865.
4. Bruderer M, Richards RG, Alini M, Stoddart MJ. 2014. Role and regulation of RUNX2 in osteogenesis. Eur Cell Mater 28:269–286.
5. Dalle Carbonare L, Innamorati G, Valenti MT. 2012. Transcription factor Runx2 and its application to bone tissue engineering. Stem Cell Rev 8:891–897.
6. Donate PB, Fornari TA, Macedo C, Cunha TM, Nascimento DC, Sakamoto-Hojo ET, Donadi EA, Cunha FQ, Passos GA. 2013. T cell post-transcriptional miRNA-mRNA interaction networks identify targets associated with susceptibility/resistance to collagen-induced arthritis. PLoS ONE 8:e54803.
7. Ducy P, Starbuck M, Priemel M, Shen J, Pinero G, Geoffroy V, Amling M, Karsenty G. 1999. A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development. Genes Dev 13:1025–1036.
8. Eguchi T, Watanabe K, Hara ES, Ono M, Kuboki T, Calderwood SK. 2013. OstemiR: A novel panel of microRNA biomarkers in osteoblastic and osteocytic differentiation from mesenchymal stem cells. PLoS ONE 8:e58796.
9. Eisen MB, Spellman PT, Brown PO, Botstein D. 1998. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 95:14863–14868.
10. Fan X, Kurgan L. 2015. Comprehensive overview and assessment of computational prediction of microRNA targets in animals. Brief Bioinform 16:780–794.
11. Fanganiello RD, Ishiy FA, Kobayashi GS, Alvizi L, Sunaga DY, Passos-Bueno MR. 2015. Increased in vitro osteopotential in SHED associated with higher IGF2 expression when compared with hASCs. Stem Cell Rev 11:635–644.
12. Fornari TA, Donate PB, Assis AF, Macedo C, Sakamoto-Hojo ET, Donadi EA, Passos GA. 2015. Comprehensive survey of miRNA-mRNA interactions reveals that Ccr7 and Cd247 (CD3 zeta) are posttranscriptionally controlled in pancreas infiltrating T lymphocytes of non-obese diabetic (NOD) mice. PLoS ONE 10:e0142688.
13. Fujie A, Funayama A, Miyauchi Y, Sato Y, Kobayashi T, Kanagawa H, Katsuyama E, Hao W, Tando T, Watanabe R, Morita M, Miyamoto K, Kanaji A, Morioka H, Matsumoto M, Toyama Y, Miyamoto T. 2015. BCL6 promotes osteoblastogenesis through STAT1 inhibition. Biochem Biophys Res Commun 457:451–456.
14. Gao J, Yang T, Han J, Yan K, Qiu X, Zhou Y, Fan Q, Ma B. 2011. MicroRNA expression during osteogenic differentiation of human multipotent mesenchymal stromal cells from bone marrow. J Cell Biochem 112:1844–1856.
15. Gómez-Picos P, Eames BF. 2015. On the evolutionary relationship between chondrocytes and osteoblasts. Front Genet 6:297.
16. Greenblatt MB, Shim JH. 2013. Osteoimmunology: A brief introduction. Immune Netw 13:111–115.
17. Gregory CA, Gunn WG, Peister A, Prockop DJ. 2004. An alizarin red-based assay of mineralization by adherent cells in culture: Comparison with cetylpyridinium chloride extraction. Anal Biochem 329:77–84.
18. Huang JC, Babak T, Corson TW, Chua G, Khan S, Gallie BL, Hughes TR, Blencowe BJ, Frey BJ, Morris QD. 2007a. Using expression profiling data to identify human microRNA targets. Nat Methods 12:1045–1049.
19. Huang JC, Morris QD, Frey BJ. 2007b. Bayesian inference of MicroRNA targets from sequence and expression data. J Comput Biol 5:550–563.
20. Jing D, Hao J, Shen Y, Tang G, Li ML, Huang SH, Zhao ZH. 2015. The role of microRNAs in bone remodeling. Int J Oral Sci 7:131–143.
21. Karsenty G. 2008. Transcriptional control of skeletogenesis. Annu Rev Genomics Hum Genet 9:1831–1896.
22. Kim S, Koga T, Isobe M, Kern BE, Yokochi T, Chin YE, Karsenty G, Taniguchi T, Takayanagi H. 2003. Stat1 functions as a cytoplasmic attenuator of Runx2 in the transcriptional program of osteoblast differentiation. Genes Dev 17:1979–1991.
23. Komori T. 2011. Signaling networks in RUNX2-dependent bone development. J Cell Biochem 112:750–755.
24. Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao YH, Inada M, Sato M, Okamoto R, Kitamura Y, Yoshiki S, Kishimoto T. 1997. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89:755–764.
25. Krüger J, Rehmsmeier M. 2006. RNAhybrid: microRNA target prediction easy, fast and flexible. Nucleic Acids Res 34(Web Server issue):W451–W454.
26. Lewis BP, Burge CB, Bartel DP. 2005. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120:15–20.
27. Li J, He X, Wei W, Zhow X. 2015. MicroRNA-194 promotes osteoblast differentiation via downregulating STAT1. Biochem Biophys Res Commun 460:482–488.
28. Lian JB, Javed A, Zaidi SK, Lengner C, Montecino M, van Wijnen AJ, Stein JL, Stein GS. 2004. Regulatory controls for osteoblast growth and differentiation: Role of Runx/Cbfa/AML factors. Crit Rev Eukaryot Gene Expr 14:1–41.
29. Lian JB, Stein GS, van Wijnen AJ, Stein JL, Hassan MQ, Gaur T, Zhang Y. 2012. MicroRNA control of bone formation and homeostasis. Nat Rev Endocrinol 8:212–227.
30. Menicanin D, Bartold PM, Zannettino AC, Gronthos S. 2010. Identification of a common gene expression signature associated with immature clonal mesenchymal cell populations derived from bone marrow and dental tissues. Stem Cells Dev 19:1501–1510.
31. Miura M, Gronthos S, Zhao M, Lu B, Fisher LW, Robey PG, Shi S. 2003. SHED: Stem cells from human exfoliated deciduous teeth. Proc Natl Acad Sci USA 100:5807–5812.
32. Mosmann T. 1983. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 65:55–63.
33. Papaioannou G, Mirzamohammadi F, Kobayashi T. 2014. MicroRNAs involved in bone formation. Cell Mol Life Sci 24:4747–4761.
34. Pasquinelli AE. 2012. MicroRNAs and their targets: Recognition, regulation and an emerging reciprocal relationship. Nat Rev Genet 13:271–282.
35. Prideaux M, Findlay DM, Atkins GJ. 2016. Osteocytes: The master cells in bone remodelling. Curr Opin Pharmacol 28:24–30.
36. Regan J, Long F. 2013. Notch signaling and bone remodeling. Curr Osteoporos Rep 11:126–129.
37. Rehmsmeier M, Steffen P, Hochsmann M, Giegerich R. 2004. Fast and effective prediction of microRNA/target duplexes. RNA 10:1507–1517.
38. Rickard DJ, Hofbauer LC, Bonde SK, Gori F, Spelsberg TC, Riggs BL. 1998. Bone morphogenetic protein-6 production in human osteoblastic cell lines. Selective regulation by estrogen. J Clin Invest 101:413–422.
39. Santibanez JF, Koic J. 2012. Transforming growth factor-β superfamily, implications in development and differentiation of stem cells. Biomol Concepts 3:429–445.
40. Sobacchi C, Schulz A, Coxon FP, Villa A, Helfrich MH. 2013. Osteopetrosis: Genetics, treatment and new insights into osteoclast function. Nat Rev Endocrinol 9:522–536.
41. Tajima K, Takahashi H, Takito J, Tohmonda T, Yoda M, Ota N, Kosaki N, Matsumoto M, Ikegami H, Nakamura T, Kimura T, Okada Y, Horiuchi K, Chiba K, Toyama Y. 2010. Inhibition of STAT1 accelerates bone fracture healing. J Orthop Res 28:937–941.
42. Takayanagi H. 2009. Osteoimmunology and the effects of the immune system on bone. Nat Rev Rheumatol 5:667–676.
43. Takayanagi H, Sato K, Takaoka A, Taniguchi T. 2005. Interplay between interferon and other cytokine systems in bone metabolism. Immunol Rev 208:181–193.
44. Tamaoki N, Takahashi K, Aoki H, Iida K, Kawaguchi T, Hatakeyama D, Inden M, Chosa N, Ishisaki A, Kunisada T, Shibata T, Goshima N, Yamanaka S, Tezuka K. 2014. The homeobox gene DLX4 promotes generation of human induced pluripotent stem cells. Sci Rep 4:7283.
45. Tompkins KA. 2016. The osteoimmunology of alveolar bone loss. Connect Tissue Res 57:69–90.
46. Vimalraj S, Arumugam B, Miranda PJ, Selvamurugan N. 2015. Runx2: Structure, function, and phosphorylation in osteoblast differentiation. Int J Biol Macromol 78:202–208.
47. Vishal M, Vimalraj S, Ajeetha R, Gokulnath M, Keerthana R, He Z, Partridge NC, Selvamurugan N. 2017. MicroRNA 590-5p stabilizes Runx2 by targeting Smad7 during osteoblast differentiation. J Cell Physiol 232:371–380.
48. Walsh MC, Choi Y. 2014. Biology of the RANKL-RANK-OPG system in immunity, bone, and beyond. Front Immunol 5:511.
49. Wang Y, Li YP, Paulson C, Shao JZ, Zhang X, Wu M, Chen W. 2014. Wnt and the Wnt signaling pathway in bone development and disease. Front Biosci (Landmark Ed) 19:379–407.
50. Weivoda MM, Ruan M, Hachfeld CM, Pederson L, Howe A, Davey RA, Zajac JD, Kobayashi Y, Williams BO, Westendorf JJ, Khosla S, Oursler MJ. 2016. Wnt signaling inhibits osteoclast differentiation by activating canonical and noncanonical cAMP/PKA pathways. J Bone Miner Res 31:65–75.
51. Wysokinski D, Pawlowska E, Blasiak J. 2015. RUNX2: A master bone growth regulator that may be involved in the DNA damage response. DNA Cell Biol 34:305–315.
52. Xu J, Li Z, Hou Y, Fang W. 2015. Potential mechanisms underlying the Runx2 induced osteogenesis of bone marrow mesenchymal stem cells. Am J Transl Res 7:2527–2535.
53. Zhang J, Tu Q, Bonewald LF, He X, Stein G, Lian J, Chen J. 2011. Effects of miR-335-5p in modulating osteogenic differentiation by specifically downregulating Wnt antagonist DKK1. J Bone Min Res 26:1953–1963.
54. Zhang X, Yang M, Lin L, Chen P, Ma KT, Zhou CY, Ao YF. 2006. Runx2 overexpression enhances osteoblastic differentiation and mineralization in adipose-derived stem cells in vitro and in vivo. Calcif Tissue Int 79:169–178.